Crossmark

Melatonin for ICU Delirium Prevention: Optimal Pharmacokinetics but No Clinical Benefit in the DEMEL Trial

Crossref DOI link: https://doi.org/10.1007/s00134-025-08037-2

Published Online: 2025-07-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Bin https://orcid.org/0000-0002-0665-0376
Huang, Peng

Liang, Yanchao

Xie, Bo
License Information

Text and Data Mining valid from 2025-07-24

Version of Record valid from 2025-07-24
More Information

Article History

Accepted: 9 July 2025

First Online: 24 July 2025

Declarations

:

: The authors declare that they have no conflict of interest.